NewGLab Pharma Co Ltd
KOSDAQ:214870
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
NewGLab Pharma Co Ltd
Operating Income
NewGLab Pharma Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
Operating Income
-â‚©11.8B
|
CAGR 3-Years
27%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
V
|
Vidente Co Ltd
KOSDAQ:121800
|
Operating Income
-â‚©8.3B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Tovis Co Ltd
KOSDAQ:051360
|
Operating Income
â‚©48.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
F
|
Furonteer Co Ltd
KOSDAQ:370090
|
Operating Income
â‚©7.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
P
|
Park Systems Corp
KOSDAQ:140860
|
Operating Income
â‚©31.8B
|
CAGR 3-Years
43%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
|
W
|
Woori Technology Inc
KOSDAQ:032820
|
Operating Income
-â‚©1.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
31%
|
CAGR 10-Years
14%
|
NewGLab Pharma Co Ltd
Glance View
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NewGLab Pharma Co Ltd's Operating Income?
Operating Income
-11.8B
KRW
Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Operating Income amounts to -11.8B KRW.
What is NewGLab Pharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-30%
Over the last year, the Operating Income growth was 38%. The average annual Operating Income growth rates for NewGLab Pharma Co Ltd have been 27% over the past three years , -30% over the past five years .